Bausch + Lomb Initiates Phase 3 Program for Glaucoma Drug Candidate …

Published January 29, 2013

Bausch + Lomb Initiates Phase 3 Program for Glaucoma Drug Candidate …

Filed under: drug treatment programs nj

SOPHIA ANTIPOLIS, France and MADISON, NJ, USA I January 29, 2013 I Bausch + Lomb, the global eye health company, and Nicox S.A. ( EURONEXT PARIS : COX ) today announced that Bausch + Lomb has initiated its Phase 3 clinical program of latanoprostene …
Read more on PipelineReview.com (press release)

MentiNova Raises 0000 for Parkinson's Treatments

Filed under: drug treatment programs nj

According to James M. Golubieski, president of FVCG, the investment in MentiNova will allow the company to advance the status of its IND (Investigational New Drug) filing with the FDA and to perform clinical trials testing the efficacy of the treatment …
Read more on Private Equity Hub (press release)

Opinion: An Explosion of Devices

Filed under: drug treatment programs nj

Coronary artery stents have been around for some years, but a new drug-eluting stent called Acrobat currently under investigation at Svelte Medical in New Providence, New Jersey, can be placed via a single catheter, rather than through multiple …
Read more on Scientist